218 related articles for article (PubMed ID: 32057899)
1. The regulation of TFEB in lipid homeostasis of non-alcoholic fatty liver disease: Molecular mechanism and promising therapeutic targets.
Yu S; Wang Z; Ding L; Yang L
Life Sci; 2020 Apr; 246():117418. PubMed ID: 32057899
[TBL] [Abstract][Full Text] [Related]
2. Formononetin alleviates hepatic steatosis by facilitating TFEB-mediated lysosome biogenesis and lipophagy.
Wang Y; Zhao H; Li X; Wang Q; Yan M; Zhang H; Zhao T; Zhang N; Zhang P; Peng L; Li P
J Nutr Biochem; 2019 Nov; 73():108214. PubMed ID: 31520816
[TBL] [Abstract][Full Text] [Related]
3. Phillygenin ameliorates nonalcoholic fatty liver disease via TFEB-mediated lysosome biogenesis and lipophagy.
Zhou W; Yan X; Zhai Y; Liu H; Guan L; Qiao Y; Jiang J; Peng L
Phytomedicine; 2022 Aug; 103():154235. PubMed ID: 35716542
[TBL] [Abstract][Full Text] [Related]
4. Ajugol enhances TFEB-mediated lysosome biogenesis and lipophagy to alleviate non-alcoholic fatty liver disease.
Zhang H; Lu J; Liu H; Guan L; Xu S; Wang Z; Qiu Y; Liu H; Peng L; Men X
Pharmacol Res; 2021 Dec; 174():105964. PubMed ID: 34732369
[TBL] [Abstract][Full Text] [Related]
5. Procyanidin B2 ameliorates free fatty acids-induced hepatic steatosis through regulating TFEB-mediated lysosomal pathway and redox state.
Su H; Li Y; Hu D; Xie L; Ke H; Zheng X; Chen W
Free Radic Biol Med; 2018 Oct; 126():269-286. PubMed ID: 30142454
[TBL] [Abstract][Full Text] [Related]
6. Transcription factor EB inhibits non-alcoholic fatty liver disease through fibroblast growth factor 21.
Gong Q; Zhang X; Sun Y; Shen J; Li X; Xue C; Liu Z
J Mol Med (Berl); 2022 Nov; 100(11):1587-1597. PubMed ID: 36102936
[TBL] [Abstract][Full Text] [Related]
7. Transcription factor EB: A potential integrated network regulator in metabolic-associated cardiac injury.
Wen W; Zheng H; Li W; Huang G; Chen P; Zhu X; Cao Y; Li J; Huang X; Huang Y
Metabolism; 2023 Oct; 147():155662. PubMed ID: 37517793
[TBL] [Abstract][Full Text] [Related]
8. Hypericin-mediated sonodynamic therapy induces autophagy and decreases lipids in THP-1 macrophage by promoting ROS-dependent nuclear translocation of TFEB.
Li X; Zhang X; Zheng L; Kou J; Zhong Z; Jiang Y; Wang W; Dong Z; Liu Z; Han X; Li J; Tian Y; Zhao Y; Yang L
Cell Death Dis; 2016 Dec; 7(12):e2527. PubMed ID: 28005078
[TBL] [Abstract][Full Text] [Related]
9. Current Advances in the Regulatory Effects of Bioactive Compounds from Dietary Resources on Nonalcoholic Fatty Liver Disease: Role of Autophagy.
Zhang Y; Chen Q; Fu X; Zhu S; Huang Q; Li C
J Agric Food Chem; 2023 Nov; 71(46):17554-17569. PubMed ID: 37955247
[TBL] [Abstract][Full Text] [Related]
10. Disturbed Vitamin A Metabolism in Non-Alcoholic Fatty Liver Disease (NAFLD).
Saeed A; Dullaart RPF; Schreuder TCMA; Blokzijl H; Faber KN
Nutrients; 2017 Dec; 10(1):. PubMed ID: 29286303
[TBL] [Abstract][Full Text] [Related]
11. Metformin Alleviates Hepatic Steatosis and Insulin Resistance in a Mouse Model of High-Fat Diet-Induced Nonalcoholic Fatty Liver Disease by Promoting Transcription Factor EB-Dependent Autophagy.
Zhang D; Ma Y; Liu J; Deng Y; Zhou B; Wen Y; Li M; Wen D; Ying Y; Luo S; Shi C; Pu G; Miao Y; Zou C; Chen Y; Ma L
Front Pharmacol; 2021; 12():689111. PubMed ID: 34366846
[TBL] [Abstract][Full Text] [Related]
12. Impaired TFEB-Mediated Lysosome Biogenesis and Autophagy Promote Chronic Ethanol-Induced Liver Injury and Steatosis in Mice.
Chao X; Wang S; Zhao K; Li Y; Williams JA; Li T; Chavan H; Krishnamurthy P; He XC; Li L; Ballabio A; Ni HM; Ding WX
Gastroenterology; 2018 Sep; 155(3):865-879.e12. PubMed ID: 29782848
[TBL] [Abstract][Full Text] [Related]
13. Role of TFEB in Autophagy and the Pathogenesis of Liver Diseases.
Yan S
Biomolecules; 2022 May; 12(5):. PubMed ID: 35625599
[TBL] [Abstract][Full Text] [Related]
14. Fibroblast growth factor 21 in lipid metabolism and non-alcoholic fatty liver disease.
Su X; Kong Y; Peng D
Clin Chim Acta; 2019 Nov; 498():30-37. PubMed ID: 31419414
[TBL] [Abstract][Full Text] [Related]
15. THOC4 regulates energy homeostasis by stabilizing
Fujita T; Kubo S; Shioda T; Tokumura A; Minami S; Tsuchiya M; Isaka Y; Ogawa H; Hamasaki M; Yu L; Yoshimori T; Nakamura S
J Cell Sci; 2021 Mar; 134(6):. PubMed ID: 33589500
[TBL] [Abstract][Full Text] [Related]
16. TFEB at a glance.
Napolitano G; Ballabio A
J Cell Sci; 2016 Jul; 129(13):2475-81. PubMed ID: 27252382
[TBL] [Abstract][Full Text] [Related]
17. Traditional Chinese herbal extracts inducing autophagy as a novel approach in therapy of nonalcoholic fatty liver disease.
Liu C; Liao JZ; Li PY
World J Gastroenterol; 2017 Mar; 23(11):1964-1973. PubMed ID: 28373762
[TBL] [Abstract][Full Text] [Related]
18. Homeostasis of Glucose and Lipid in Non-Alcoholic Fatty Liver Disease.
Chao HW; Chao SW; Lin H; Ku HC; Cheng CF
Int J Mol Sci; 2019 Jan; 20(2):. PubMed ID: 30642126
[TBL] [Abstract][Full Text] [Related]
19. Free radical biology for medicine: learning from nonalcoholic fatty liver disease.
Serviddio G; Bellanti F; Vendemiale G
Free Radic Biol Med; 2013 Dec; 65():952-968. PubMed ID: 23994574
[TBL] [Abstract][Full Text] [Related]
20. Water Extract of Dolichos lablab Attenuates Hepatic Lipid Accumulation in a Cellular Nonalcoholic Fatty Liver Disease Model.
Im AR; Kim YH; Lee HW; Song KH
J Med Food; 2016 May; 19(5):495-503. PubMed ID: 27152979
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
